CD30 was initially discovered on neoplastic Reed–Sternberg cells in Hodgkin’s disease, and its overexpression has since been associated with constitutive NF-κB signaling that may promote cell growth and malignancy (43). The gene discussed is NFKB1; the disease is Hodgkins lymphoma.